Assessment & Research

The reliability of the Scale for the Evaluation and Identification of Seizures, Epilepsy, and Anticonvulsant Side Effects-B (SEIZES B).

Matson et al. (2005) · Research in developmental disabilities 2005
★ The Verdict

SEIZES B is a quick, reliable scale you can start using tomorrow to spot anticonvulsant side effects in adults with ID/DD.

✓ Read this if BCBAs who support adults with ID/DD and epilepsy in residential or day programs.
✗ Skip if Clinicians working only with children or clients without seizures.

01Research in Context

01

What this study did

Baker et al. (2005) tested how well the SEIZES B scale works.

Staff rated the same adults with ID/DD twice to see if scores matched.

They wanted a quick way to track anticonvulsant side effects in day programs.

02

What they found

Different raters gave very similar scores.

Scores stayed steady when the same rater checked again later.

The scale is reliable enough for everyday use.

03

How this fits with other research

Farrant et al. (1998) built an earlier carer scale for epilepsy in ID adults. SEIZES B updates that work by adding side-effect items.

Burack et al. (2004) said we need structured caregiver interviews. SEIZES B gives you the form to do it.

Arcieri et al. (2015) warned that up to 39% of events in disabled children may be misdiagnosed seizures. Using SEIZES B each week can catch real side effects and cut false alarms.

04

Why it matters

You now have a five-minute checklist that travels with the client.

Add it to nurse rounds or family visits.

When scores jump, you have data to show the doctor and can rule out behavioral causes faster.

Free CEUs

Want CEUs on This Topic?

The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.

Join Free →
→ Action — try this Monday

Print the SEIZES B form and ask the morning nurse to rate each client before breakfast.

02At a glance

Intervention
not applicable
Design
other
Population
intellectual disability, developmental delay
Finding
positive
Magnitude
medium

03Original abstract

The use of anti-epileptic medications (AEDs) is much higher in individuals with intellectual disabilities than in the general population. As many of these individuals rely on such medications, clinicians should consider psychometrically sound instruments for assessing adverse side effects of these medications as one aspect of routine clinical practice. The Scale for the Evaluation and Identification of Seizures, Epilepsy, and Anticonvulsant Side Effects-B (SEIZES B) was developed as a means to identify side effects specific to AEDs. The authors conducted a preliminary evaluation of the inter-rater and test-retest reliability of the SEIZES B on an adult population with developmental disabilities. The SEIZES B had moderately high stability across raters and adequate stability over time. Implications of these data for future research and practice are discussed.

Research in developmental disabilities, 2005 · doi:10.1016/j.ridd.2004.11.011